메뉴 건너뛰기




Volumn 19, Issue 4, 2013, Pages 457-461

Use of rifabutin for the treatment of a latent tuberculosis infection in a patient after solid organ transplantation

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; KETOCONAZOLE; MEROPENEM; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RIFABUTIN; RIFAMPICIN; TACROLIMUS; VANCOMYCIN;

EID: 84875737056     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23622     Document Type: Article
Times cited : (23)

References (30)
  • 1
    • 79952430844 scopus 로고    scopus 로고
    • Detection and management of latent tuberculosis in liver transplant patients
    • Jafri SM, Singal AG, Kaul D, Fontana RJ,. Detection and management of latent tuberculosis in liver transplant patients. Liver Transpl 2011; 17: 306-314.
    • (2011) Liver Transpl , vol.17 , pp. 306-314
    • Jafri, S.M.1    Singal, A.G.2    Kaul, D.3    Fontana, R.J.4
  • 2
    • 0032450187 scopus 로고    scopus 로고
    • Mycobacterium tuberculosis infection in solid-organ transplant recipients: Impact and implications for management
    • Singh N, Paterson DL,. Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management. Clin Infect Dis 1998; 27: 1266-1277.
    • (1998) Clin Infect Dis , vol.27 , pp. 1266-1277
    • Singh, N.1    Paterson, D.L.2
  • 4
    • 69949097461 scopus 로고    scopus 로고
    • Tuberculosis in liver transplant recipients: A systematic review and meta-analysis of individual patient data
    • Holty JE, Gould MK, Meinke L, Keeffe EB, Ruoss SJ,. Tuberculosis in liver transplant recipients: a systematic review and meta-analysis of individual patient data. Liver Transpl 2009; 15: 894-906.
    • (2009) Liver Transpl , vol.15 , pp. 894-906
    • Holty, J.E.1    Gould, M.K.2    Meinke, L.3    Keeffe, E.B.4    Ruoss, S.J.5
  • 5
    • 74349091157 scopus 로고    scopus 로고
    • Mycobacterium tuberculosis infection in transplant recipients: Early diagnosis and treatment of resistant tuberculosis
    • Holty JE, Sista RR,. Mycobacterium tuberculosis infection in transplant recipients: early diagnosis and treatment of resistant tuberculosis. Curr Opin Organ Transpl 2009; 14: 613-618.
    • (2009) Curr Opin Organ Transpl , vol.14 , pp. 613-618
    • Holty, J.E.1    Sista, R.R.2
  • 6
    • 83155184045 scopus 로고    scopus 로고
    • Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection
    • Centers for Disease Control and Prevention (CDC)
    • Centers for Disease Control and Prevention (CDC). Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection. MMWR Morb Mortal Wkly Rep 2011; 60: 1650-1653.
    • (2011) MMWR Morb Mortal Wkly Rep , vol.60 , pp. 1650-1653
  • 7
    • 65549101056 scopus 로고    scopus 로고
    • Tuberculosis in solid-organ transplant recipients: Consensus statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology
    • Aguado JM, Torre-Cisneros J, Fortún J, Benito N, Meije Y, Doblas A, Muñoz P,. Tuberculosis in solid-organ transplant recipients: consensus statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology. Clin Infect Dis 2009; 48: 1276-1284.
    • (2009) Clin Infect Dis , vol.48 , pp. 1276-1284
    • Aguado, J.M.1    Torre-Cisneros, J.2    Fortún, J.3    Benito, N.4    Meije, Y.5    Doblas, A.6    Muñoz, P.7
  • 8
    • 0037441632 scopus 로고    scopus 로고
    • For American Thoracic Society, Centers for Disease Control and Prevention; Infectious Diseases Society. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Treatment of tuberculosis
    • Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN, et al.; for American Thoracic Society, Centers for Disease Control and Prevention; Infectious Diseases Society. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 2003; 167: 603-662.
    • (2003) Am J Respir Crit Care Med , vol.167 , pp. 603-662
    • Blumberg, H.M.1    Burman, W.J.2    Chaisson, R.E.3    Daley, C.L.4    Etkind, S.C.5    Friedman, L.N.6
  • 9
    • 0034625247 scopus 로고    scopus 로고
    • American Thoracic Society
    • Targeted tuberculin testing and treatment of latent tuberculosis infection
    • Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMWR Recomm Rep 2000; 49: 1-51.
    • (2000) MMWR Recomm Rep , vol.49 , pp. 1-51
  • 10
    • 16644391540 scopus 로고    scopus 로고
    • Mycobacterium tuberculosis
    • Mycobacterium tuberculosis. Am J Transplant 2004; 4 (suppl 10): 37-41.
    • (2004) Am J Transplant , vol.4 , Issue.SUPPL. 10 , pp. 37-41
  • 11
    • 79952114997 scopus 로고    scopus 로고
    • Acute liver failure due to antitubercular therapy: Strategy for antitubercular treatment before and after liver transplantation
    • Ichai P, Saliba F, Antoun F, Azoulay D, Sebagh M, Antonini TM, et al. Acute liver failure due to antitubercular therapy: strategy for antitubercular treatment before and after liver transplantation. Liver Transpl 2010; 16: 1136-1146.
    • (2010) Liver Transpl , vol.16 , pp. 1136-1146
    • Ichai, P.1    Saliba, F.2    Antoun, F.3    Azoulay, D.4    Sebagh, M.5    Antonini, T.M.6
  • 12
    • 77958003198 scopus 로고    scopus 로고
    • Tuberculosis in renal transplant recipients: The evidence for prophylaxis
    • Currie AC, Knight SR, Morris PJ,. Tuberculosis in renal transplant recipients: the evidence for prophylaxis. Transplantation 2010; 90: 695-704.
    • (2010) Transplantation , vol.90 , pp. 695-704
    • Currie, A.C.1    Knight, S.R.2    Morris, P.J.3
  • 14
    • 29544433285 scopus 로고    scopus 로고
    • Prospective randomized control trial of isoniazid chemoprophylaxis during renal replacement therapy
    • Vikrant S, Agarwal SK, Gupta S, Bhowmik D, Tiwari SC, Dash SC, et al. Prospective randomized control trial of isoniazid chemoprophylaxis during renal replacement therapy. Transpl Infect Dis 2005; 7: 99-108.
    • (2005) Transpl Infect Dis , vol.7 , pp. 99-108
    • Vikrant, S.1    Agarwal, S.K.2    Gupta, S.3    Bhowmik, D.4    Tiwari, S.C.5    Dash, S.C.6
  • 15
    • 33947731010 scopus 로고    scopus 로고
    • Liver transplantation without isoniazid prophylaxis for recipients with a history of tuberculosis
    • Nagai S, Fujimoto Y, Taira K, Egawa H, Takada Y, Kiuchi T, Tanaka K,. Liver transplantation without isoniazid prophylaxis for recipients with a history of tuberculosis. Clin Transplant 2007; 21: 229-234.
    • (2007) Clin Transplant , vol.21 , pp. 229-234
    • Nagai, S.1    Fujimoto, Y.2    Taira, K.3    Egawa, H.4    Takada, Y.5    Kiuchi, T.6    Tanaka, K.7
  • 16
    • 34250811391 scopus 로고    scopus 로고
    • Safety of treatment of latent tuberculosis infection in compensated cirrhotic patients during transplant candidacy period
    • Jahng AW, Tran T, Bui L, Joyner JL,. Safety of treatment of latent tuberculosis infection in compensated cirrhotic patients during transplant candidacy period. Transplantation 2007; 83: 1557-1562.
    • (2007) Transplantation , vol.83 , pp. 1557-1562
    • Jahng, A.W.1    Tran, T.2    Bui, L.3    Joyner, J.L.4
  • 17
    • 0037183875 scopus 로고    scopus 로고
    • Safety and efficacy of isoniazid chemoprophylaxis administered during liver transplant candidacy for the prevention of posttransplant tuberculosis
    • Singh N, Wagener MM, Gayowski T,. Safety and efficacy of isoniazid chemoprophylaxis administered during liver transplant candidacy for the prevention of posttransplant tuberculosis. Transplantation 2002; 74: 892-895.
    • (2002) Transplantation , vol.74 , pp. 892-895
    • Singh, N.1    Wagener, M.M.2    Gayowski, T.3
  • 18
    • 56549116367 scopus 로고    scopus 로고
    • Adverse events with 4 months of rifampin therapy or 9 months of isoniazid therapy for latent tuberculosis infection: A randomized trial
    • Menzies D, Long R, Trajman A, Dion MJ, Yang J, Al Jahdali H, et al. Adverse events with 4 months of rifampin therapy or 9 months of isoniazid therapy for latent tuberculosis infection: a randomized trial. Ann Intern Med 2008; 149: 689-697.
    • (2008) Ann Intern Med , vol.149 , pp. 689-697
    • Menzies, D.1    Long, R.2    Trajman, A.3    Dion, M.J.4    Yang, J.5    Al Jahdali, H.6
  • 19
    • 33749014430 scopus 로고    scopus 로고
    • Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: A retrospective study
    • Page KR, Sifakis F, Montes de, Oca R, Cronin WA, Doherty MC, Federline L, et al. Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study. Arch Intern Med 2006; 166: 1863-1870.
    • (2006) Arch Intern Med , vol.166 , pp. 1863-1870
    • Page, K.R.1    Sifakis, F.2    De, M.3    Oca, R.4    Cronin, W.A.5    Doherty, M.C.6    Federline, L.7
  • 21
    • 33644697765 scopus 로고    scopus 로고
    • Exposure-response relationships and drug interactions of sirolimus
    • Zimmerman JJ,. Exposure-response relationships and drug interactions of sirolimus. AAPS J 2004; 6: e28.
    • (2004) AAPS J , vol.6
    • Zimmerman, J.J.1
  • 22
    • 0030964429 scopus 로고    scopus 로고
    • Combined use of astemizole and ketoconazole resulting in torsade de pointes
    • Tsai WC, Tsai LM, Chen JH,. Combined use of astemizole and ketoconazole resulting in torsade de pointes. J Formos Med Assoc 1997; 96: 144-146.
    • (1997) J Formos Med Assoc , vol.96 , pp. 144-146
    • Tsai, W.C.1    Tsai, L.M.2    Chen, J.H.3
  • 24
    • 0030055907 scopus 로고    scopus 로고
    • The clinical pharmacokinetics of rifabutin
    • Blaschke TF, Skinner MH,. The clinical pharmacokinetics of rifabutin. Clin Infect Dis 1996; 22 (suppl 1): S15-S21.
    • (1996) Clin Infect Dis , vol.22 , Issue.SUPPL. 1
    • Blaschke, T.F.1    Skinner, M.H.2
  • 26
    • 0027970431 scopus 로고
    • Rifabutin for the treatment of newly-diagnosed pulmonary tuberculosis: A multinational, randomized, comparative study versus rifampicin. Rifabutin Study Group
    • Gonzalez-Montaner LJ, Natal S, Yongchaiyud P, Olliaro P,. Rifabutin for the treatment of newly-diagnosed pulmonary tuberculosis: a multinational, randomized, comparative study versus rifampicin. Rifabutin Study Group. Tuber Lung Dis 1994; 75: 341-347.
    • (1994) Tuber Lung Dis , vol.75 , pp. 341-347
    • Gonzalez-Montaner, L.J.1    Natal, S.2    Yongchaiyud, P.3    Olliaro, P.4
  • 28
    • 0029043965 scopus 로고
    • A pilot study of antituberculosis combinations comparing rifabutin with rifampicin in the treatment of HIV-1 associated tuberculosis. A single-blind randomized evaluation in Ugandan patients with HIV-1 infection and pulmonary tuberculosis
    • Schwander S, Rüsch-Gerdes S, Mateega A, Lutalo T, Tugume S, Kityo C, et al. A pilot study of antituberculosis combinations comparing rifabutin with rifampicin in the treatment of HIV-1 associated tuberculosis. A single-blind randomized evaluation in Ugandan patients with HIV-1 infection and pulmonary tuberculosis. Tuber Lung Dis 1995; 76: 210-218.
    • (1995) Tuber Lung Dis , vol.76 , pp. 210-218
    • Schwander, S.1    Rüsch-Gerdes, S.2    Mateega, A.3    Lutalo, T.4    Tugume, S.5    Kityo, C.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.